STOCK TITAN
  1. Home
  2. News
  3. CNMD

CONMED Corporation - $CNMD STOCK NEWS

Welcome to our dedicated page for CONMED Corporation news (Ticker: $CNMD), a resource for investors and traders seeking the latest updates and insights on CONMED Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CONMED Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CONMED Corporation's position in the market.

News
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) will participate in fireside chats at two investor conferences in November. The first conference is the Stifel Healthcare Conference in New York, NY on November 14, 2023, where Curt R. Hartman and Eric Staves will be the speakers. The second conference is the Jefferies London Healthcare Conference in London, UK on November 15, 2023, where Todd W. Garner and Pat J. Beyer will be the speakers. The fireside chats will be accessible through the Company's website and will be available for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
-
News
CONMED Corporation Announces Third Quarter 2023 Financial Results
Rhea-AI Summary
CONMED Corporation reports third quarter 2023 financial results with sales of $304.6 million, a 10.7% increase YoY. Diluted net earnings per share (GAAP) were $0.50 compared to $1.48 in Q3 2022. The company expects full-year revenue between $1.240 billion and $1.260 billion and adjusted diluted net earnings per share in the range of $3.45 to $3.55.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.95%
Tags
earnings
-
News
CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) will report Q3 2023 financial results on October 25. Conference call at 4:30 p.m. ET to discuss the results. Webcast replay available on company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.5%
Tags
earnings
News
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
Rhea-AI Summary
CONMED Corporation CFO to participate in virtual fireside chat at CL King 21st Annual Best Ideas Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
conferences
-
News
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
Rhea-AI Summary
CONMED Corporation CFO to participate in fireside chat at Wells Fargo Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
conferences
-
News
CONMED Corporation Announces Quarterly Cash Dividend
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share. The dividend will be payable on October 5, 2023, to all shareholders of record as of September 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
dividends
News
Palliare Announces EU CE Mark Approval Under New Medical Devices Regulation
Rhea-AI Summary
Palliare Signs first US GPO Agreement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
-
News
CONMED Corporation Announces Second Quarter 2023 Financial Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
earnings
-
News
CONMED Corporation to Announce Second Quarter 2023 Financial Results on July 26, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
earnings
News
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Healthcare Conference
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
conferences
Stock CNMD logo
CONMED Corporation

NYSE:CNMD

CNMD Rankings

#1829 Ranked by Market Cap
#947 Ranked by Stock Gains
#1769 Ranked by Dividends

CNMD Stock Data

2.21B
30.52M
0.54%
119.07%
13.2%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LARGO

About CNMD

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500